Loading...
Please wait, while we are loading the content...
Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas
| Content Provider | Scilit |
|---|---|
| Author | Frank, Matthew J. Dawson, David W. Bensinger, Steven J. Hong, Jason S. Knosp, Wendy M. Xu, Lizhong Balatoni, Cynthia E. Allen, Eric L. Shen, Rhine R. Bar-Sagi, Dafna Martin, Gail R. Teitell, Michael A. |
| Copyright Year | 2009 |
| Description | B-cell lymphoma is the most common immune system malignancy. TCL1 transgenic mice (TCL1-tg), in which TCL1 is ectopically expressed in mature lymphocytes, develop multiple B- and T-cell leukemia and lymphoma subtypes, supporting an oncogenic role for TCL1 that probably involves AKT and MAPK-ERK signaling pathway augmentation. Additional, largely unknown genetic and epigenetic alterations cooperate with TCL1 during lymphoma progression. We examined DNA methylation patterns in TCL1-tg B-cell tumors to discover tumor-associated epigenetic changes, and identified hypermethylation of sprouty2 (Spry2). Sprouty proteins are context-dependent negative or positive regulators of MAPK-ERK pathway signaling, but their role(s) in B-cell physiology or pathology are unknown. Here we show that repression of Spry2 expression in TCL1-tg mouse and human B-cell lymphomas and cell lines is associated with dense DNA hypermethylation and was reversed by inhibition of DNA methylation. Spry2 expression was induced in normal splenic B cells by CD40/B-cell receptor costimulation and regulated a negative feedback loop that repressed MAPK-ERK signaling and decreased B-cell viability. Conversely, loss of Spry2 function hyperactivated MAPK-ERK signaling and caused increased B-cell proliferation. Combined, these results implicate epigenetic silencing of Spry2 expression in B lymphoma progression and suggest it as a companion lesion to ectopic TCL1 expression in enhancing MAPK-ERK pathway signaling. |
| Related Links | http://www.bloodjournal.org/content/113/11/2478.full.pdf |
| Ending Page | 2487 |
| Page Count | 10 |
| Starting Page | 2478 |
| DOI | 10.1182/blood-2008-05-156943 |
| Journal | Blood |
| Issue Number | 11 |
| Volume Number | 113 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2009-03-12 |
| Access Restriction | Open |
| Subject Keyword | Research and Experimental Medicine Tcl1 Cell Lymphomas Mapk Erk Epigenetically Silenced Cell Proliferation Dna Methylation Journal: Blood (Vol- 117, Issue- 11) |
| Content Type | Text |
| Resource Type | Article |